These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Rationale for prescribing oral contraceptives]. Teichmann AT Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865 [TBL] [Abstract][Full Text] [Related]
6. [Letter: Relative estrogen deficiency caused by contraceptives]. Bailer P Dtsch Med Wochenschr; 1973 Nov; 98(45):2162. PubMed ID: 4757978 [TBL] [Abstract][Full Text] [Related]
8. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781 [TBL] [Abstract][Full Text] [Related]
10. [Hormonal contraception--side effects and surgical aspects (author's transl)]. Göretzlehner G; Carol W; Köhler G Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744 [TBL] [Abstract][Full Text] [Related]
11. Reversed-phase high-performance liquid chromatography for the determination of steroid hormones in oral contraceptives. Bond AM; Heritage ID; Briggs MH J Chromatogr; 1984 Dec; 315():313-20. PubMed ID: 6526900 [TBL] [Abstract][Full Text] [Related]
12. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data]. Gaspard U; Dubois M Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606 [TBL] [Abstract][Full Text] [Related]
13. [The benefit of the classification of oral contraceptives. Studies of 525 women taking oral contraceptives (author's transl)]. Wenderlein JM MMW Munch Med Wochenschr; 1981 Jun; 123(23):957-61. PubMed ID: 6789156 [TBL] [Abstract][Full Text] [Related]
14. [Routines for prescription of contraceptives (estrogen+gestagen)]. Nesheim BI; Bergsjø P Tidsskr Nor Laegeforen; 1979 Feb; 99(3):180-1. PubMed ID: 419499 [No Abstract] [Full Text] [Related]
15. Oral contraception and thromboembolism: the role of progestogens. N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346 [TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive formulation and ovarian cysts: FDA committee finds no increased risk of follicular enlargement with low-dose monophasic or triphasic preparations. Contracept Rep; 1994 Mar; 5(1):6-9. PubMed ID: 12287739 [TBL] [Abstract][Full Text] [Related]
17. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. van Leeuwen FE Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500 [TBL] [Abstract][Full Text] [Related]
18. Experiences in dermatology with various contraceptives containing gestagen. Vankos J Gyogyszereink; 1972; 22():59-67. PubMed ID: 12256240 [TBL] [Abstract][Full Text] [Related]
19. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives. Holt VL; Daling JR; McKnight B; Moore D; Stergachis A; Weiss NS Obstet Gynecol; 1992 Apr; 79(4):529-33. PubMed ID: 1553170 [TBL] [Abstract][Full Text] [Related]
20. [Drug information. This is how hormonal contraceptives act]. Dahlerup J Sygeplejersken; 1986 Sep; 86(36):20-2. PubMed ID: 3639645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]